Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial

American Journal of Transplantation

Volumn 16, Issue 10, 2016, Pages 2943-2953

  Origüen, Julia ^a   Lopez Medrano F ^a   Fernandez Ruiz M ^a   Polanco, N ^a   Gutierrez E ^a   Gonzalez E ^a   Merida E ^a   Ruiz Merlo, T ^a   Morales Cartagena, A ^a   Perez Jacoiste Asin M A ^a   Garcia Reyne A ^a   San Juan, R ^a   Orellana, M A ^a   Andres A ^a   Aguado, J M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; COTRIMOXAZOLE; PENTAMIDINE; THYMOCYTE ANTIBODY; ANTIINFECTIVE AGENT;

ACUTE GRAFT REJECTION; ACUTE PYELONEPHRITIS; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DIARRHEA; DRUG INDICATION; END STAGE RENAL DISEASE; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; INDWELLING URINARY CATHETER; INTENTION TO TREAT ANALYSIS; KIDNEY TRANSPLANTATION; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTIDRUG RESISTANCE; NAUSEA; OBSTRUCTIVE UROPATHY; OPEN STUDY; OUTCOME ASSESSMENT; PNEUMOCYSTIS JIROVECI; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; REINFECTION; SEROMA; SURGICAL INFECTION; TREATMENT OUTCOME; URINARY TRACT FISTULA; URINARY TRACT INFECTION; URINE CULTURE; URINE SAMPLING; BACTERIUM; BACTERIURIA; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPLICATION; DRUG EFFECTS; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY FUNCTION TEST; MICROBIOLOGY; PROGNOSIS; PYELONEPHRITIS; RISK FACTOR;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIURIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PYELONEPHRITIS; RISK FACTORS;

EID: 84971261583     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13829     Document Type: Article

References (33)

1. Lorenz EC, Cosio FG. The impact of urinary tract infections in renal transplant recipients. Kidney Int 2010; 78: 719–721.
2. Vidal E, Torre-Cisneros J, Blanes M, et al. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis 2012; 14: 595–603.
3. Golebiewska JE, Debska-Slizien A, Rutkowski B. Urinary tract infections during the first year after renal transplantation: One center’s experience and a review of the literature. Clin Transplant 2014; 28: 1263–1270.
4. Fiorante S, López-Medrano F, Lizasoain M, et al. Systematic screening and treatment of asymptomatic bacteriuria in renal transplant recipients. Kidney Int 2010; 78: 774–781.
5. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A. Hooton TM; Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643–654.
6. Kazemier BM, Koningstein FN, Schneeberger C, et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis 2015; 15: 1324–1333.
7. Asscher AW, Sussman M, Waters WE, et al. Asymptomatic significant bacteriuria in the non-pregnant woman. II. Response to treatment and follow-up. Br Med J 1969; 1: 804–806.
8. Harding GK, Zhanel GG, Nicolle LE, Cheang M. Manitoba Diabetes Urinary Tract Infection Study G. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002; 347: 1576–1583.
9. Boscia JA, Kobasa WD, Knight RA, Abrutyn E, Levison ME, Kaye D. Therapy vs no therapy for bacteriuria in elderly ambulatory nonhospitalized women. JAMA 1987; 257: 1067–1071.
10. Nicolle LE, Mayhew WJ, Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med 1987; 83: 27–33.
11. Ditunno JF Jr, Formal CS. Chronic spinal cord injury. N Engl J Med 1994; 330: 550–556.
12. Cardenas DD, Hooton TM. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil 1995; 76: 272–278.
13. Warren JW, Hoopes JM, Muncie HL, Anthony WC. Ineffectiveness of cephalexin in treatment of cephalexin-resistant bacteriuria in patients with chronic indwelling urethral catheters. J Urol 1983; 129: 71–73.
14. Coussement J, Abramowicz D. Should we treat asymptomatic bacteriuria after renal transplantation? Nephrol Dial Transplant 2014; 29: 260–262.
15. Parasuraman R, Julian K. AST Infectious Diseases Community of Practice. Urinary tract infections in solid organ transplantation. Am J Transplant 2013; 13(Suppl 4): 327–336.
16. Singh R, Geerlings SE, Bemelman FJ. Asymptomatic bacteriuria and urinary tract infections among renal allograft recipients. Curr Opin Infect Dis 2015; 28: 112–116.
17. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(Suppl 3): S1–S155.
18. Snydman DR. Posttransplant microbiological surveillance. Clin Infect Dis 2001; 33(Suppl 1): S22–S25.
19. Fiorante S, Fernández-Ruiz M, López-Medrano F, et al. Acute graft pyelonephritis in renal transplant recipients: Incidence, risk factors and long-term outcome. Nephrol Dial Transplant 2011; 26: 1065–1073.
20. Pellé G, Vimont S, Levy PP, et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant 2007; 7: 899–907.
21. Pigrau-Serrallach C. Recurrent urinary tract infections. Enferm Infecc Microbiol Clin 2005; 23(Suppl 4): 28–39.
22. Origüen J, Fernández-Ruiz M, López-Medrano F, et al. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options. Transpl Infect Dis 2016; In press.
23. Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis 2006; 8: 140–147.
24. Valera B, Gentil MA, Cabello V, Fijo J, Cordero E, Cisneros JM. Epidemiology of urinary infections in renal transplant recipients. Transplant Proc 2006; 38: 2414–2415.
25. Bodro M, Sanclemente G, Lipperheide I, et al. Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients. Am J Transplant 2015; 15: 1021–1027.
26. Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases: European Society of Clinical Microbiology and Infectious Diseases (ESCMID). treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009; 15: 1067–1079.
27. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268–281.
28. European Expert Group on Renal Transplantation (EBPG); European Renal Association (ERA-EDTA); European Society for Organ Transplantation (ESOT). European Best Practice Guidelines for Renal Transplantation (part 1. Nephrol Dial Transplant 2000; 15(Suppl 7): 1–85.
29. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461–470.
30. Cantón R, Alós JI, Baquero F, et al. [Recommendations for selecting antimicrobial agents for in vitro susceptibility studies using automatic and semiautomatic systems]. Enferm Infecc Microbiol Clin 2007; 25: 394–400.
31. El Amari EB, Hadaya K, Bühler L, et al. Outcome of treated and untreated asymptomatic bacteriuria in renal transplant recipients. Nephrol Dial Transplant 2011; 26: 4109–4114.
32. Green H, Rahamimov R, Goldberg E, et al. Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: Retrospective observational study. Eur J Clin Microbiol Infect Dis 2013; 32: 127–131.
33. Moradi M, Abbasi M, Moradi A, Boskabadi A, Jalali A. Effect of antibiotic therapy on asymptomatic bacteriuria in kidney transplant recipients. Urol J 2005; 2: 32–35.